National Institutes of Health: Sepsis trials

The registry lists 11 Sepsis studies with National Institutes of Health as lead sponsor. 1 are open to participants now and 2 have results posted.

Phase 1 1Phase 2 1Phase 3 2No phase 7(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Immune Dysregulation During Sepsis: A Natural History CohortNot yet recruitingNCT07735741
• Statins for Acutely Injured Lungs From SepsisTerminatedNCT00979121Phase 3Results posted
• Randomized Trial of Inhaled Nitric Oxide to Augment Tissue Perfusion in SepsisCompletedNCT00608322Phase 3Results posted
• Adjunctive Clindamycin Versus Linezolid for β-lactam Treated Patients With Invasive Group A Streptococcal InfectionsActive, not recruitingNCT06126263
• Impact of COVID-19 on the Incidence, Characteristics, Management and Outcome of SepsisWithdrawnNCT04698382
• Evaluation of MiSeq for Microbial Identification in SpecimensCompletedNCT02578875
• Detoxified J5 Core Glycolipid/ Group B Meningococcal Outer Membrane Protein Vaccine for Gram-negative Bacterial Sepsis Administered With and Without Synthetic CPG Oligodeoxynucleotide 7909 AdjuvantTerminatedNCT01164514Phase 1
• Clinical Trial of the Optimal Endpoint of Early Sepsis ResuscitationCompletedNCT00372502Not applicable
• Protocol-driven Hemodynamic Support for Patients With Septic ShockStatus unknownNCT00335907Not applicable
• Pleconaril Enteroviral Sepsis SyndromeCompletedNCT00031512Phase 2
• Study of the Relationship Between Feeding and Late Onset Sepsis and/or Necrotizing Enterocolitis in Low Birth Weight InfantsCompletedNCT00005888Not applicable